Desq Long
Sign in

Company

Editas Medicine, Inc.

EDIT · CIK 0001650664

SEC FORM 4
$15,562.61

Editas Medicine, Inc. (EDIT)

Sale of 5,124 shares at $3.0372 per share.

Reporting Person O'Neill Gilmore Neil · Officer Title CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001742084-26-000003 · filed 2026-09-04 · View filing →

SEC FORM 4
$2,153.37

Editas Medicine, Inc. (EDIT)

Sale of 709 shares at $3.0372 per share.

Reporting Person Burkly Linda · Officer Title EVP, CHIEF SCIENTIFIC OFFICER · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001985604-26-000003 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,375.85

Editas Medicine, Inc. (EDIT)

Sale of 453 shares at $3.0372 per share.

Reporting Person Parison Amy · Officer Title SVP, Chief Financial Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002063082-26-000006 · filed 2026-09-04 · View filing →